10-Q Filing

MERCK & CO., INC. CIK: 310158 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0000310158-18-000034`
Period End Date	20180630
Filing Date	20180807
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	mrk-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 60 Cash Flow Statement 62 Comprehensive Income 28

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$210.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$210.00M	USD	Point-in-time
Inventories classified in Other assets	`InventoryNoncurrent`	$1.19B	USD	Point-in-time
Inventories classified in Other assets	`InventoryNoncurrent`	$1.36B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.60B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.31B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.57B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.09B	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.28B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.50	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.50	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.41B	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	6.50B	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $210 in both 2018 and 2017)	`AccountsReceivableNetCurrent`	$6.87B	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	6.50B	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $210 in both 2018 and 2017)	`AccountsReceivableNetCurrent`	$7.29B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Inventories (excludes inventories of $1,361 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7)	`InventoryNet`	$5.18B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Inventories (excludes inventories of $1,361 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7)	`InventoryNet`	$5.10B	USD	Point-in-time
Other current assets	`DeferredIncomeTaxesAndOtherAssetsCurrent`	$4.30B	USD	Point-in-time
Treasury stock, shares (shares)	`TreasuryStockShares`	907.06M	shares	Point-in-time
Other current assets	`DeferredIncomeTaxesAndOtherAssetsCurrent`	$4.00B	USD	Point-in-time
Treasury stock, shares (shares)	`TreasuryStockShares`	880.49M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$24.77B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$24.06B	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$10.03B	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$12.12B	USD	Point-in-time
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,567 in 2018 and $16,602 in 2017	`PropertyPlantAndEquipmentNet`	$12.44B	USD	Point-in-time
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,567 in 2018 and $16,602 in 2017	`PropertyPlantAndEquipmentNet`	$12.63B	USD	Point-in-time
Goodwill	`Goodwill`	$18.27B	USD	Point-in-time
Goodwill	`Goodwill`	$18.28B	USD	Point-in-time
Other Intangibles, Net	`IntangibleAssetsNetExcludingGoodwill`	$12.90B	USD	Point-in-time
Other Intangibles, Net	`IntangibleAssetsNetExcludingGoodwill`	$14.18B	USD	Point-in-time
Other Assets	`DeferredIncomeTaxesAndOtherAssetsNoncurrent`	$6.08B	USD	Point-in-time
Other Assets	`DeferredIncomeTaxesAndOtherAssetsNoncurrent`	$7.14B	USD	Point-in-time
Total Assets	`Assets`	$87.87B	USD	Point-in-time
Total Assets	`Assets`	$85.04B	USD	Point-in-time
Loans payable and current portion of long-term debt	`DebtCurrent`	$3.38B	USD	Point-in-time
Loans payable and current portion of long-term debt	`DebtCurrent`	$3.06B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$3.10B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$3.02B	USD	Point-in-time
Accrued and other current liabilities	`OtherLiabilitiesCurrent`	$9.76B	USD	Point-in-time
Accrued and other current liabilities	`OtherLiabilitiesCurrent`	$10.43B	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$661.00M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$708.00M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$1.32B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$1.31B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.13B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.61B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$19.96B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$21.35B	USD	Point-in-time
Deferred Income Taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.22B	USD	Point-in-time
Deferred Income Taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.16B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$12.03B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$11.12B	USD	Point-in-time
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017	`CommonStockValue`	$1.79B	USD	Point-in-time
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017	`CommonStockValue`	$1.79B	USD	Point-in-time
Other paid-in capital	`AdditionalPaidInCapitalCommonStock`	$39.74B	USD	Point-in-time
Other paid-in capital	`AdditionalPaidInCapitalCommonStock`	$39.90B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$41.52B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$41.35B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.91B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.12B	USD	Point-in-time
Stockholders' equity before deduction for treasury stock	`StockholdersEquityBeforeTreasuryStock`	$78.13B	USD	Point-in-time
Stockholders' equity before deduction for treasury stock	`StockholdersEquityBeforeTreasuryStock`	$77.93B	USD	Point-in-time
Less treasury stock, at cost: 907,061,576 shares in 2018 and 880,491,914 shares in 2017	`TreasuryStockValue`	$43.79B	USD	Point-in-time
Less treasury stock, at cost: 907,061,576 shares in 2018 and 880,491,914 shares in 2017	`TreasuryStockValue`	$45.40B	USD	Point-in-time
Total Merck & Co., Inc. stockholders equity	`StockholdersEquity`	$34.34B	USD	Point-in-time
Total Merck & Co., Inc. stockholders equity	`StockholdersEquity`	$32.53B	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$233.00M	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$237.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$39.71B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$32.77B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$34.57B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$40.31B	USD	Point-in-time
Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$85.04B	USD	Point-in-time
Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$87.87B	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Sales	`Revenues`	$20.50B	USD	2 Qtrs
Sales	`Revenues`	$9.93B	USD	1 Quarter
Sales	`Revenues`	$10.46B	USD	1 Quarter
Sales	`Revenues`	$19.36B	USD	2 Qtrs
Materials and production	`CostOfGoodsAndServicesSold`	$3.12B	USD	1 Quarter
Materials and production	`CostOfGoodsAndServicesSold`	$3.42B	USD	1 Quarter
Materials and production	`CostOfGoodsAndServicesSold`	$6.60B	USD	2 Qtrs
Materials and production	`CostOfGoodsAndServicesSold`	$6.17B	USD	2 Qtrs
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$2.50B	USD	1 Quarter
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$4.97B	USD	2 Qtrs
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$5.02B	USD	2 Qtrs
Marketing and administrative	`SellingGeneralAndAdministrativeExpense`	$2.51B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.61B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.78B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.47B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.27B	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$317.00M	USD	2 Qtrs
Restructuring costs	`RestructuringCharges`	$323.00M	USD	2 Qtrs
Restructuring costs	`RestructuringCharges`	$228.00M	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$166.00M	USD	1 Quarter
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$48.00M	USD	1 Quarter
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$340.00M	USD	2 Qtrs
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$143.00M	USD	2 Qtrs
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$73.00M	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$7.49B	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$14.92B	USD	2 Qtrs
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$8.38B	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$17.07B	USD	2 Qtrs
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.09B	USD	1 Quarter
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.43B	USD	2 Qtrs
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.44B	USD	1 Quarter
Income Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.44B	USD	2 Qtrs
Taxes on Income	`IncomeTaxExpenseBenefit`	$370.00M	USD	1 Quarter
Taxes on Income	`IncomeTaxExpenseBenefit`	$935.00M	USD	2 Qtrs
Taxes on Income	`IncomeTaxExpenseBenefit`	$488.00M	USD	1 Quarter
Taxes on Income	`IncomeTaxExpenseBenefit`	$975.00M	USD	2 Qtrs
Net Income	`ProfitLoss`	$1.72B	USD	1 Quarter
Net Income	`ProfitLoss`	$2.46B	USD	2 Qtrs
Net Income	`ProfitLoss`	$1.95B	USD	1 Quarter
Net Income	`ProfitLoss`	$3.51B	USD	2 Qtrs
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	2 Qtrs
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$14.00M	USD	2 Qtrs
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Less: Net Income Attributable to Noncontrolling Interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.00M	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$2.44B	USD	2 Qtrs
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.95B	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.71B	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$3.50B	USD	2 Qtrs
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.91	USD	2 Qtrs
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.64	USD	1 Quarter
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$0.71	USD	1 Quarter
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareBasic`	$1.28	USD	2 Qtrs
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$1.27	USD	2 Qtrs
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.90	USD	2 Qtrs
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.63	USD	1 Quarter
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share)	`EarningsPerShareDiluted`	$0.71	USD	1 Quarter
Dividends Declared per Common Share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.94	USD	2 Qtrs
Dividends Declared per Common Share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.48	USD	1 Quarter
Dividends Declared per Common Share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.47	USD	1 Quarter
Dividends Declared per Common Share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.96	USD	2 Qtrs

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCashAndCashEquivalents`	$2.00M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$4.00M	USD	Point-in-time
Net income	`ProfitLoss`	$1.72B	USD	1 Quarter
Net income	`ProfitLoss`	$2.46B	USD	2 Qtrs
Net income	`ProfitLoss`	$1.95B	USD	1 Quarter
Net income	`ProfitLoss`	$3.51B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.35B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.36B	USD	2 Qtrs
Intangible asset impairment charges	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$131.00M	USD	2 Qtrs
Intangible asset impairment charges	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	2 Qtrs
Charge for future payments related to Eisai collaboration license options	`ChargeForLicenseOptionsRelatedToCollaboration`	$650.00M	USD	2 Qtrs
Charge for future payments related to Eisai collaboration license options	`ChargeForLicenseOptionsRelatedToCollaboration`	-	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-272.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-258.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$170.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$156.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$82.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$90.00M	USD	1 Quarter
Other	`OtherNoncashIncomeExpense`	$-63.00M	USD	2 Qtrs
Other	`OtherNoncashIncomeExpense`	$-429.00M	USD	2 Qtrs
Net changes in assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$2.34B	USD	2 Qtrs
Net changes in assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$1.27B	USD	2 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$3.60B	USD	2 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$4.54B	USD	2 Qtrs
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$1.03B	USD	2 Qtrs
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$732.00M	USD	2 Qtrs
Purchases of securities and other investments	`PaymentsToAcquireMarketableSecurities`	$6.28B	USD	2 Qtrs
Purchases of securities and other investments	`PaymentsToAcquireMarketableSecurities`	$5.25B	USD	2 Qtrs
Proceeds from sales of securities and other investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$7.40B	USD	2 Qtrs
Proceeds from sales of securities and other investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$9.36B	USD	2 Qtrs
Other acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$347.00M	USD	2 Qtrs
Other acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$372.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-62.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$274.00M	USD	2 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$2.07B	USD	2 Qtrs
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$476.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$-24.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$2.07B	USD	2 Qtrs
Payments on debt	`RepaymentsOfLongTermDebt`	$3.01B	USD	2 Qtrs
Payments on debt	`RepaymentsOfLongTermDebt`	$301.00M	USD	2 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$2.15B	USD	2 Qtrs
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$2.16B	USD	2 Qtrs
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$2.61B	USD	2 Qtrs
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$2.60B	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$299.00M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$408.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-277.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-86.00M	USD	2 Qtrs
Net Cash Used in Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-5.69B	USD	2 Qtrs
Net Cash Used in Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.76B	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-108.00M	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$359.00M	USD	2 Qtrs
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.27B	USD	2 Qtrs
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-784.00M	USD	2 Qtrs
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.31B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.79B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.51B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.10B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.31B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.79B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.51B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $4 million at January 1, 2018 included in Other Assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.10B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$2.44B	USD	2 Qtrs
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.95B	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$1.71B	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$3.50B	USD	2 Qtrs
Net unrealized gain (loss) on derivatives, net of reclassifications	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$-375.00M	USD	2 Qtrs
Net unrealized gain (loss) on derivatives, net of reclassifications	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$266.00M	USD	1 Quarter
Net unrealized gain (loss) on derivatives, net of reclassifications	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$196.00M	USD	2 Qtrs
Net unrealized gain (loss) on derivatives, net of reclassifications	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$-143.00M	USD	1 Quarter
Net unrealized gain (loss) on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$78.00M	USD	2 Qtrs
Net unrealized gain (loss) on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-96.00M	USD	2 Qtrs
Net unrealized gain (loss) on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$35.00M	USD	1 Quarter
Net unrealized gain (loss) on investments, net of reclassifications	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$3.00M	USD	1 Quarter
Benefit plan net gain and prior service credit, net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-47.00M	USD	1 Quarter
Benefit plan net gain and prior service credit, net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-30.00M	USD	1 Quarter
Benefit plan net gain and prior service credit, net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-66.00M	USD	2 Qtrs
Benefit plan net gain and prior service credit, net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-73.00M	USD	2 Qtrs
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-104.00M	USD	2 Qtrs
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$356.00M	USD	2 Qtrs
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-361.00M	USD	1 Quarter
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$47.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-14.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-62.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$132.00M	USD	2 Qtrs
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$62.00M	USD	2 Qtrs
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$1.65B	USD	1 Quarter
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$3.63B	USD	2 Qtrs
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$2.50B	USD	2 Qtrs
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$1.93B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.